GR1000403B - Νεα ανοσοδιαγνωστικη μεθοδος - Google Patents

Νεα ανοσοδιαγνωστικη μεθοδος

Info

Publication number
GR1000403B
GR1000403B GR900100011A GR900100011A GR1000403B GR 1000403 B GR1000403 B GR 1000403B GR 900100011 A GR900100011 A GR 900100011A GR 900100011 A GR900100011 A GR 900100011A GR 1000403 B GR1000403 B GR 1000403B
Authority
GR
Greece
Prior art keywords
anosodiagnostic
new
antigens
neurocysticization
parasite
Prior art date
Application number
GR900100011A
Other languages
English (en)
Other versions
GR900100011A (en
Inventor
A Chandramukhi
B V Kumar
V Ravi
V Suryanarayana
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of GR900100011A publication Critical patent/GR900100011A/el
Publication of GR1000403B publication Critical patent/GR1000403B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0003Invertebrate antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4355Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from cestodes
    • C07K14/43554Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from cestodes from Taenia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Κοινολογείται μια μέθοδος απόκτησης αντιγόνων Cysticercus cellulosae διατηρώντας το παράσιτο in vitro. Τα αντιγόνα αυτά χρησιμοποιούμενα σε μια συνδεμένη με ένζυμο ανοσορροφητική δοκιμασία αποδείχτηκαν χρήσιμα για την ανίχνευση των περιπτώσεων νευροκυστικήρωσης. ω
GR900100011A 1989-01-24 1990-01-09 Νεα ανοσοδιαγνωστικη μεθοδος GR1000403B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19898900243A SE8900243D0 (sv) 1989-01-24 1989-01-24 A novel immunodiagnostic method

Publications (2)

Publication Number Publication Date
GR900100011A GR900100011A (en) 1991-06-07
GR1000403B true GR1000403B (el) 1992-06-30

Family

ID=20374839

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100011A GR1000403B (el) 1989-01-24 1990-01-09 Νεα ανοσοδιαγνωστικη μεθοδος

Country Status (15)

Country Link
EP (1) EP0456686B1 (el)
JP (1) JPH04502814A (el)
KR (1) KR910700460A (el)
CN (1) CN1045184A (el)
AT (1) ATE135823T1 (el)
BR (1) BR9007047A (el)
DE (1) DE69026076D1 (el)
FI (1) FI913530A7 (el)
GR (1) GR1000403B (el)
HU (1) HUT56971A (el)
MX (1) MX19155A (el)
OA (1) OA09500A (el)
PT (1) PT92950A (el)
SE (1) SE8900243D0 (el)
WO (1) WO1990008958A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4614313B2 (ja) * 2004-06-22 2011-01-19 学校法人北里研究所 簡便かつ迅速で安全なq熱診断方法および診断薬
CN101275140B (zh) * 2007-12-27 2012-05-09 中国农业科学院兰州兽医研究所 猪囊尾蚴病重组基因、疫苗及其制备方法
JP5582521B2 (ja) * 2009-04-10 2014-09-03 国立大学法人旭川医科大学 嚢虫症診断用抗原の精製方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740456A (en) * 1985-08-15 1988-04-26 Wake Forest University Immunological methods for diagnosing neurocysticercosis

Also Published As

Publication number Publication date
SE8900243D0 (sv) 1989-01-24
DE69026076D1 (de) 1996-04-25
BR9007047A (pt) 1991-11-12
GR900100011A (en) 1991-06-07
OA09500A (en) 1992-11-15
CN1045184A (zh) 1990-09-05
EP0456686A1 (en) 1991-11-21
ATE135823T1 (de) 1996-04-15
EP0456686B1 (en) 1996-03-20
MX19155A (es) 1993-10-01
KR910700460A (ko) 1991-03-15
FI913530A0 (fi) 1991-07-23
HUT56971A (en) 1991-10-28
FI913530A7 (fi) 1991-07-23
PT92950A (pt) 1990-07-31
WO1990008958A1 (en) 1990-08-09
JPH04502814A (ja) 1992-05-21

Similar Documents

Publication Publication Date Title
ES8801440A1 (es) Un metodo de ensayo mejorado para la determinacion de analitos bioligicos tales como haptenos, antigenos ,receptores , farmacos y similares.
JO1536B1 (en) Cement composition curable at low temperatures
ES2038109T1 (es) Un proceso para la produccion de un compuesto alqueno.
ES2138102T3 (es) Procedimiento para la deteccion de antigeno urinario asociado a tumores.
FI843409A0 (fi) Fluorometer.
KR890700803A (ko) 평면결정을 위한 단일접촉점 거리측정
MY100371A (en) Immunoassay for antigents employing supported binder
FI880742A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, 7-asemassa substituoitujen 19-norsteroidien valmistamiseksi
GR1000403B (el) Νεα ανοσοδιαγνωστικη μεθοδος
FI883585L (fi) Menetelmä verihiutalesolun pinta-antigeenin läsnäolon toteamiseksi
FI881355A7 (fi) Määritysmenetelmä hepatiittiantigeenien ja AIDS-vasta-aineiden toteamiseksi.
DK140387D0 (da) Paavisning af haptener ved immunoanalysemetoder
ATE69322T1 (de) Einrichtung zur kartenfuehrung.
FI883671A7 (fi) Menetelmä analyytin visuaaliseksi määrittämiseksi
PT86643A (pt) Method for measuring anti-dna antibodies
FI882057A0 (fi) Menetelmä polarisoitujen fluoresenssiemissioiden mittaamiseksi
FR2325934A1 (fr) Methode de detection de la presence d'un antigene associe a l'hepatite
EP0266686A3 (en) Latex agglutination method for the detection of an antibody against streptococcus deoxyribonuclease b
FI884652L (fi) Menetelmä t-PA-kaltaisten proteiinien tuotannon tehostamiseksi
NO171758C (no) Boeyelig gjennomgangsskjoet for undervannskabler med impregnert papirisolasjon
FI865165A7 (fi) Menetelmä ja reagenssi testosteronin määrittämiseksi sekä sen vasta-aineet.
SE8304218D0 (sv) Prostaglandinderivat
FI883156L (fi) Kretsmodul med ett plattformigt kretsunderlag av glas eller keramik.
FI870500A7 (fi) Reagenssi virus-antigeenin vasta-aineen määrittämiseksi.
IT1206039B (it) Procedimento per la produzione di etanolo mediante ceppi di microorganismo ad elevata resistenza